ABSTRACT Hybrid voltage sensors (hVoS) probe membrane potential by coupling the fluorescence of membrane-anchored proteins to the movement of a membrane-embedded hydrophobic anion dipicrylamine. Fluorescence resonance energy transfer between these two components transduces voltage changes into fluorescence changes, providing a signal for imaging electrical activity in genetically targeted cells. To improve hVoS signals, we systematically varied the optical properties, membrane targeting motifs, and linkages of fluorescent proteins to optimize the normalized fluorescence change (DF/F) and signal/noise ratio. The best results were obtained with cerulean fluorescent protein tagged N-terminally with a GAP43 motif and C-terminally with a truncated h-ras motif. With 100 mV steps in PC12 cells, this probe produced DF/F ¼ 26% (4 mM dipicrylamine), which was threefold greater than that obtained with the original farnesylated EGFP construct. We also obtained a fivefold greater signal/noise ratio, which was 70% of a theoretical optimum. We designate this GAP43-CerFP-t-h-ras construct as hVoS 2.0. With the aid of a theoretical analysis, we estimated that hVoS 2.0 places its fluorophore~40 Å from the bilayer midplane. hVoS 2.0 performed well in cultured hippocampal neurons, where single action potentials produced clear fluorescence changes in a single trial. This improved probe should help investigators image voltage in genetically targeted neurons.
INTRODUCTION
Optical imaging of electrical activity offers a promising approach to the investigation of neural circuitry. The most widely used methods involve staining with voltage-sensitive dyes (VSDs) (1) (2) (3) (4) , which bind cell membranes and report voltage changes as changes in absorption or fluorescence. These dyes have linear responses to voltage and microsecond response times (5) but stain cells indiscriminately to produce higher background light levels and mixed signals from different cell types. These probes cannot readily resolve the electrical activity of distinct populations of cells with different functions.
Genetically encoded voltage probes offer an attractive solution to the problem of nonspecific cell labeling. Fluorescent proteins can be targeted to specific groups of neurons by genetic methods, and when a fluorescent protein has the capacity to transduce membrane potential it becomes a genetically encoded voltage sensor. One class of voltage sensors can be generated by fusing voltage sensor domains of voltage gated ion channels with a fluorescent protein. The FlaSH voltage sensor is generated by attaching green fluorescent protein (GFP) to the Shaker K þ channel (6) , and the SPARK voltage sensor incorporates GFP between domains I and II of a Na þ channel (7) . Fluorescence resonance energy transfer (FRET) between CFP and YFP was also employed when these two proteins were fused to the end of the voltage-sensing domain of a voltage-gated ion channel (8) or a voltage-sensitive protein phosphatase (9) . Although considerable progress has been made in this area (9) (10) (11) (12) , there is still a general need for genetically-encoded voltage probes that produce larger fluorescence changes, have faster response times, and target the plasma membrane more efficiently.
The hybrid voltage sensor (hVoS) method represents another promising strategy for genetically encoded voltage sensors (13) . This method builds on the FRET method pioneered by González and Tsien (14) , in which a synthetic fluorescent label at the membrane surface interacts by FRET with a negatively charged, lipid-soluble fluorescent anion in the hydrophobic core of the lipid bilayer. Replacing the surface label with a membrane-targeted GFP, and the lipophilic fluorophore with the nonfluorescent anionic absorber, dipicrylamine (DPA), preserves the fundamental interaction between the two components (13) . The spectral overlap of GFP emission with DPA absorbance produces FRET, so that when voltage changes drive DPA across the membrane, the distance changes and the fluorescence emission follows suit (see Fig. 1 A) . hVOS has been used to measure voltage changes in GT1 cells and HEK cells, as well as action potentials in neurons and muscle fibers (15) . These successes justify an effort to improve the performance of hVoS probes. In this study we generated a number of GFP variants with different optical properties and membrane attachment motifs. These probes were then screened as in previous studies by expression in cells and subsequent simultaneous voltage clamping and fluorometry (15, 16) . These studies resulted in probes with substantially improved performance.
MATERIALS AND METHODS

Voltage imaging
A CCD-SMQ camera (Redshirt Imaging, Decatur, GA) was used to image fluorescence. This camera can acquire up to 2000 frames/s with a resolution of 80Â80 pixels. A Uniblitz electronic shutter under computer control limited illumination to the time of data acquisition. The camera was mounted on an Olympus BX51 fluorescence microscope equipped with 
Patch-clamp recording
Whole-cell patch-clamp recordings were performed with an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). Cultured PC12 cells and hippocampal neurons were bathed in a solution containing (in mM) 140 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 10 glucose (pH 7.4). Patch electrodes were filled with (in mM) 130 K-gluconate, 10 EGTA, 5 HEPES, 5 phosphocreatine, 2 Mg-ATP, and 0.3 Na-GTP (pH ¼ 7.3).
Molecular cloning
For GAP43 constructs, the GAP43 membrane targeting sequence was inserted into the EGFP-N1 vector by HandIII and AgeI restriction sites.
For EYFP-h-ras, the EYFP sequence was subcloned with the NheI and BsrGI sites of EGFP-h-ras. For other clones we used the EGFP-h-ras backbone and NheI and XhoI restriction sites. Table 1 shows the domain maps of these constructs with their membrane targeting motifs, linkers, and XFPs.
Cell culture and transfection PC12 cells were cultured in Dulbecco's modified Eagle's medium with 5% horse serum and 5% iron-supplemented calf serum at 37 C in a humidified incubator with a 90% air/10% CO 2 atmosphere. Cells were transfected by electroporation with an ECM 830 electroporator (BTX, San Diego, CA) and plated on collagen-poly-D-lysine-coated coverslips. Cells were used 2-3 days after transfection (17) .
The hippocampus of E-18 rat embryos was dissected and digested with trypsin for 30 min followed by trituration (18) . The cell suspension was plated on poly-D-lysine-coated coverslips in 24-well plates in Neurobasal-A Medium (600 mL/well) together with B27 and 2 mM Glutamax, FIGURE 1 (A) Schematic illustration of the hVoS method. A fluorescent protein (XFP) resides at the inner surface of a cell membrane. Negative potentials (left) drive negatively charged DPA (red circles) toward the outer membrane surface, away from the XFP. Depolarization (right) pulls DPA toward the XFP, thus increasing FRET efficiency. hVoS performance was tested with different fluorescent proteins. (See Table 1 
Software and analysis
Imaging and patch-clamp data were acquired separately with two computers. For imaging, we used Neuroplex, the program provided with the CCD-SMQ camera. In the Neuroplex user interface, we specified the stimulation protocol, data acquisition rate, and shutter control. The data were analyzed with different pixel resolutions, baseline corrections, and high-and lowpass filtering. To compare different probes, we used unfiltered data.
We used two indices to evaluate probe performance: 1), normalizing the fluorescence change (for steps from À70 to þ30 mV) to the resting light intensity gave the fractional fluorescence change (DF/F); and 2), dividing DF by the root mean-square baseline noise gave the signal/noise (S/N) ratio (2, 3, 20) . These two measures are useful indices of performance between different probes tested in the same way in this laboratory. However, because they depend on the details of the instrumentation, the quantities of DF/F, and especially the S/N ratio, should be evaluated with caution in comparisons with other published studies of probe performance. Means are presented plus or minus standard errors, and differences were evaluated for statistical significance using Student's t-test.
RESULTS hVoS optimization strategies
To optimize voltage-induced fluorescence changes, we generated a series of hVoS probes using green, yellow, cyan, cerulean, and teal fluorescent proteins (EGFP, ECFP, EYFP, CeFP, and TeFP, respectively) and different membrane-targeting motifs. Table 1 summarizes the domain maps of these constructs. R 0 for FRET with DPA was computed from the XFP emission spectrum and DPA absorption spectrum. Brightness was calculated from the peak extinction and quantum yield. Parameters used for this table were taken from http://www.microscopyu.com/articles/livecellimaging/fpintro.html, except for the TeFP parameters, which were obtained from Ai et al. (22) .
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properties of the XFPs, including brightness and R 0 for FRET with DPA.
XFP optimization
We expressed XFP fused to the h-ras farnesylation motif at the C-terminus in PC12 cells. EGFP-h-ras fluorescence can be seen in Fig. 1 , B and C. Simultaneous patch-clamp and fluorescence recordings show that in 4 mM DPA a 100 mV voltage step (from À70 to þ30 mV) produced large, clearly visible fluorescence changes in a single trial (Fig. 1 D) . Averaging 20 trials improved the S/N ratio ( Fig. 1 E) . Some probes were also tested with a photodiode array (20) (data not shown), and the CCD-SMQ camera produced dramatically better signals. The traces in Fig. 1 , D and E, illustrate the pronounced nonlinearity of hVoS signals: the depolarizing pulses evoked much greater fluorescence changes than the hyperpolarizing pulses. This is a wellknown feature of hVoS (13, 15, 16 ) and other FRET-based voltage imaging techniques (14,21) (see Fig. 5 B for a plot that displays this nonlinearity). Because the signals are nearly linear in the range of À70 to þ30 mV (13, 15, 16) , the fluorescence changes with steps between these voltages serve as a useful measure of probe performance. Different XFP constructs were used to evaluate the impact of spectral properties. DF/F and the S/N ratio are compared in Fig. 1 , F and G. Blue-shifted proteins produced larger signals with a better S/N ratio, as reported previously (15, 16) . This indicates that increasing R 0 improves the performance of the hVoS probe. The S/N ratio was evaluated at different levels of spatial resolution by binning signals of adjacent pixels. Theoretically, the S/N ratio will increase linearly with the square root of the number of pixels when the measurement is limited by shot noise. Fig. 1 G shows the expected increase at low pixel number, but at high pixel number the plots saturate. This could reflect 1), larger areas that include nonfluorescent regions in the field of view; or 2), a crossover to noise domination by another source, such as fluctuations in the light source intensity. We can expect a brighter XFP to increase the S/N ratio, as demonstrated by the comparison between CeFP and ECFP ( Table 2) . Because of the importance of brightness, we tested TeFP (22) , which is twice as bright as CeFP. This construct served as a slightly better hVoS probe than CeFP-h-ras ( Fig. 1 G) , but unfortunately in neurons it targeted the plasma membrane poorly (data not shown).
Optimization of membrane targeting
Choosing EGFP and CeFP as representative fluorescent proteins, we varied the membrane anchor in an effort to improve probe performance further. In addition to the h-ras farnesylation motif used in previous hVoS studies (13, 15, 16) , we tested the k-ras farnesylation motif, which carries a positive charge (23) , the transmembrane domain of syntaxin 1A (24) , and the N-terminal palmitoylation sequence of GAP43/neuromodulin (25) ( Table 1) . Of these probes, the GAP43 motif with CeFP gave the best signals in terms of both DF/F and S/N ratio (Fig. 2 , A and C).
The length of the membrane anchor motif also affects hVoS signals (16), so we deleted six amino acids in the C-terminus of EGFP and CeFP (Table 1) . These residues FIGURE 2 hVoS performance with different plasma membrane targeting motifs (see Table 1 ). (A) Comparison of k-ras, syntaxin, and GAP43 motifs for EGFP (left) and CeFP (right). (B) EGFP (left) and CeFP (right) were tested with truncated k-ras or truncated h-ras at the N-terminus, and double-tagging with C-terminal GAP-43 and N-terminal truncated h-ras. (C and D) S/N ratio of probes with different membrane anchors for which DF/F is shown in A and B.
[DPA] ¼ 4 mM. All recordings were made in PC12 cells with À70 to þ30 mV steps (as in Fig. 1 ).
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are not necessary for fluorescence (26) , and removing them should tether the fluorophore more closely to the lipid bilayer. Shorter membrane-anchoring motifs increased DF/F (Fig. 2, A and B ; compare with Fig. 1 F) . The truncated h-ras motif gave the largest S/N ratio when attached to either EGFP or CeFP (Figs. 2 C and 3 D) . We also tested a double anchoring strategy, with GAP43 at the N-terminus and truncated h-ras at the C-terminus. Two double-tagged constructs, GAP43-EGFP-t-h-ras and GAP43-CeFP-t-hras, performed very well (Fig. 2) . The effectiveness of this double-targeting strategy probably reflects closer proximity to the plasma membrane, but restricted orientation of the b-barrel of the protein, and fluorophore within, may also play a role. Of all the probes tested in this study, the GAP43-CeFP-t-h-ras construct gave the best performance, with threefold greater DF/F and fivefold greater S/N ratio compared to EGFP-h-ras (the probe tested in the original version of the method (13)). To our knowledge, this construct represents a new generation of hVoS probes, and therefore we have designated it hVoS 2.0.
Orientation and expression
FRET efficiency depends on the orientation between the donor and acceptor transition dipoles. To test the role of orientation in hVoS performance, we designed a circularly permuted version of CeFP (27) , which places the membrane anchor motif on a different side of the fluorescent protein and should rotate the axis of the protein and its fluorophore by 90 . This construct, termed circularly permuted CeFP (cpCeFP)-h-ras, failed to target to the plasma membrane well (data not shown) and thus was not suitable for hVoS imaging. Other circularly permuted XFPs have also been reported to target poorly to the plasma membrane (28) . Although the unpermutated construct TeFP-h-ras performed slightly better than CeFP-h-ras in PC12 cells (Fig. 1, F and G) , in neurons it targeted very poorly to the plasma membrane (data not shown). Fortunately, double tagging does not compromise membrane targeting, and neurons expressing GAP43-CeFP-t-h-ras display bright plasma membrane fluorescence.
We also expressed XFPs on the outer surface of the plasma membrane (Fig. 3 A) . We attached the syntaxin 1A membrane anchor to the N-termini of ECFP and EYFP and also attached a GPI motif to the N-terminus of the pH-sensitive GFP pHluorin. As expected, these constructs generated hVoS signals of the opposite sign (13) . pHfluorin-GPI produced the best signals (Fig. 3, C and D) , but they were all generally smaller than those obtained from probes expressed at the inner membrane face. At this point it is Biophysical Journal 99(7) 2355-2365 difficult to determine whether the inner surface is an advantageous location for hVoS, or whether the attachment motifs for extracellular presentation do not place the XFP at optimal distances from the bilayer interior. However, these results support the concept of a ratiometric hVoS probe with XFPs on both sides of the membrane, so that the readings of two spectral channels can be used to convert fluorescence to membrane potential.
Estimating XFP distance and probe optimization
We performed a theoretical analysis of hVoS to examine how probe performance should vary with key parameters under experimental control (Appendix), deriving the signal dependence on R 0 , R d (the distance from the donor fluorophore within XFP to the bilayer midplane; see the sketch in the upper-left corner of Fig. 4) , and s, the density of DPA in the membrane. Our measurements of DF/F are plotted in Fig. 4 versus R 0 (values from Table 2), together with the theoretical predictions for R d ¼ 30, 40, 50, and 60 Å generated from Eq. A8, assuming that DPA moves 2.5 nm between the two planes illustrated in Fig. 4 (see Appendix). The s-value was estimated from capacitance measurements described below (see Fig. 7 C) to be 10 À4 DPA molecules/Å 2 . The data points for the h-ras and k-ras constructs show the expected dependence on R 0 and fall between theoretical plots for R d ¼ 50 and 60 Å , so we estimate that R d is~55 Å for these membrane-anchoring motifs. With the truncated k-ras motif the points rose to slightly above the curve for R d ¼ 50 Å , and with the truncated h-ras motif the points were slightly below the curve for R d ¼ 40 Å . The points for the two double-tagged constructs were close to the R d ¼ 40 Å curve. These comparisons provide rough estimates of R d for different targeting motifs, although our lack of information about probe orientation qualifies these estimates, especially for the double-tagged constructs, which have more restricted orientations. We do not know whether the membrane environment restricts the orientation of DPA, and this analysis assumed DPA to be isotropic.
The Appendix presents plots of fluorescence changes versus R d for different values of R 0 (Fig. 8) .
À4
DPA molecules/Å 2 , the maximal fluorescence change normalized to the fluorescence in the absence of DPA, DF max /F 0 (from Eq. A7), has a maximum of 0.30 at R 0 ¼ 62 Å and R d ¼ 57 Å (indicated by the dotted line in Fig. 8 A) . DF max /F, plotted in Fig. 8 B, does not exhibit a maximum for finite values of R 0 and R d . The most important benchmark for probe performance is the S/N ratio, which has its maximum at R 0 ¼ 79 Å and R d ¼ 72 Å (indicated by the dotted line in Fig. 8 C) . The plots of S/N ratio versus R d indicate that for R 0 ¼ 50 Å and R d~4 5 Å the S/N ratio is quite close to the maximum (Fig. 8 C) . For the CeFP in hVoS 2.0 R 0 ¼ 41 Å (Table 2) , and with R d~4 0 Å based on Fig. 4 , Eq. A9 yields an S/N ratio that is 70% of the maximum, indicating that hVoS 2.0 is close to optimal with respect to R 0 and R d .
hVoS2.0 performance in PC12 cells and neurons
Because hVoS 2.0 gave the best performance in PC12 cells, we tested it further. Fig. 5 A shows fluorescence changes in PC12 cells for a series of voltage steps for both single trials and averages of 20. Even a 20 mV voltage step produced a clear signal in a single sweep. These traces illustrate the nonlinearity discussed above in regard to Fig. 1 . We plotted DF/F versus voltage in Fig. 5 B to illustrate that the nonlinearity obtained with hVoS 2.0 closely resembles that reported for other hVoS probes (13, 15, 16) . These fluorescence changes disappeared after we removed DPA, demonstrating that they result from a FRET interaction (Fig. 5 C) . Even voltage changes of 400 mV failed to produce a detectable signal without DPA.
As noted above, hVoS 2.0 expressed in neurons well and showed good plasma membrane targeting. With 2 mM DPA (instead of 4 mM) a 100 mV step evoked a DF/F of~20% (Fig. 6 A) . Action potentials were evoked in these neurons under current clamp ( Fig. 6 B1) ; a single trial produced a fluorescence change that could be seen in single pixels of the 80Â80 chip of the CCD-SMQ camera (Fig. 6 B2; sites indicated by numbers in the image on the left, traces in the middle and right). In comparison to a single trial (Fig. 6 B2,  middle) , the averages of 10 trials revealed these fluorescence changes more clearly (Fig. 6 B2, right) . For the study of network activity, the resolution of single cells is sufficient and spatial binning can be implemented. Combining 8Â8 adjacent pixels revealed these fluorescence changes much more clearly in both single trials (Fig. 6 B3, middle) and (Table 2) . Theoretical predictions are plotted as smooth curves based on Eq. A8 of the Appendix for various values of R d , the distance between the XFP fluorophore, and the lipid bilayer midplane (sketch, upper left).
Biophysical Journal 99(7) 2355-2365 averages of 10 ( Fig. 6 B3, right) . These results indicate that action potentials can be detected in neurons with a single trial with subcellular resolution. However, given the limitations of bandwidth imposed by the time for DPA to cross the membrane (13, 15, 21) , as well as our 1 kHz digitization rate, these signals provide only limited information about action potential shape.
Testing DPA pharmacological activity DPA increases the capacitance of lipid bilayers, and this can perturb membrane excitability (13, 15, 29) . Previous studies reported that 2 mM DPA completely abolished electrically evoked responses in Drosophila antenna lobe (16) , but these studies used synaptophluorin to measure responses, and this probe is quenched by DPA (21) . To evaluate the concentration range over which DPA can be used without pharmacological or toxic effects, we patchclamped cultured neurons and recorded action potentials and miniature excitatory postsynaptic currents (mEPSCs) in the presence of 0, 2, and 4 mM DPA. DPA did not block evoked or spontaneous action potentials, and did not change the amplitudes of evoked action potentials (Fig. 7 A) . The action potential decay time increased slightly, but the difference only became statistically significant at 4 mM (Fig. 7 A, middle) . mEPSCs could be recorded in DPA (Fig. 7 B) , and the cumulative amplitude distributions were only slightly altered. The mean amplitude and decay time increased slightly, but again the changes were only significant for 4 mM. At 2 mM DPA, the action potential and mEPSC rise times were indistinguishable from controls (Fig. 7 B) .
To evaluate the capacitance changes, we returned to PC12 cells, whose round shape permits accurate space clamping. Voltage steps produced a charging transient that was integrated to estimate charge and thus capacitance. DPA increased the charging transient (Fig. 7 C) with a voltage dependence that resembles a Boltzmann function, as expected for the two-state nature of DPA movement within lipid bilayers (29, 30) . The capacitance change occurred between -70 and 30 mV, with increments of 11% and 32% for 2 and 4 mM DPA, respectively (Fig. 7 C, lower panel) .
DISCUSSION
We attempted to improve hVoS by systematically varying key properties of the XFPs, one of the two essential components of this system. The XFP emission spectrum is important because it influences the efficiency of FRET with DPA. Although FRET is essential for hVoS, it does not necessarily follow that increasing XFP-DPA FRET will improve the performance of an hVoS probe. This was demonstrated with our theoretical analysis shown in the Appendix. If R 0 is too long or R d too short, FRET efficiency will be high when DPA resides on either the inner or outer edge of the lipid bilayer. This will reduce the fluorescence changes resulting from DPA movement. Two XFP-DPA distances must be considered: 1), the longer distance, R 1 , at negative membrane potentials; and 2), the shorter distance, R 2 , at positive membrane potentials (see Fig. 4 ). The fact that Biophysical Journal 99 (7) 2355-2365 our data and previously reported data (15, 16) showed larger DF/F values with blue-shifted fluorescent proteins with longer R 0 indicates that even with CFP and CeFP, R 0 is still less than or equal to this optimal value. This is consistent with our finding and a previous report (16) that shorter linkers increased DF/F for both GFP and CeFP (Fig. 2) . Proteins with shorter wavelength emission are likely to improve performance further, but based on our estimate that hVoS 2.0 has an S/N ratio that is 70% of the maximum for Eq. A9 with s ¼ 10 À4 DPA molecules/Å 2 , it is unlikely that refinements in XFP to enhance FRET with DPA will produce a major improvement in probe performance. Greater improvements in the S/N ratio may be realized through increased probe brightness. That is why CeFP gave us a higher S/N ratio than CFP (Fig. 1 G) . Making brighter XFPs with higher expression is thus a more promising strategy for improving hVoS. Improving the efficiency of plasma membrane targeting should also improve probe performance. Fig. 1 B shows that although most of the fluorescence emanates from the cell surface, some fluorescence emanates from the cell interior, and this will reduce both DF/F and the S/N ratio. Eliminating this cytoplasmic fluorescence can thus be expected to improve signal quality. The membrane-targeting motif contributes to probe performance by influencing both the distance of the XFP to the bilayer core and the efficiency of targeting to the plasma membrane. We found that the double-tagged CeFP (hVoS2.0), with a GAP43 membrane anchor motif at the N-terminus and a truncated h-ras motif at the C-terminus, gave the best signals. The double-tagged probe may have improved the signal not only by reducing R d , but also by fixing the orientation of the fluorophore. As an alternative approach to controlling XFP orientation, we generated a circularly permuted CeFP construct (cpCeFP), but poor targeting to the plasma membrane (similar to TeFP) precluded a test of its performance. We also tested probes that target the XFP to the outer membrane surface (Fig. 3 ), but these probes did not perform as well as probes at the inner surface, probably because they had greater values of R d .
In this work we generated hVoS 2.0 as a potentially useful probe for voltage imaging. The signals are nonlinear, with the greatest changes occurring in a voltage range in which physiological important events are generally manifest. By contrast, synthetic dyes are linear over a much broader range of voltages (2, 4, 5, 31) . We observed high-quality signals with 20 mV voltage steps in PC12 cells. This probe showed very good expression and efficient membrane targeting in hippocampal neurons. Because DPA translocates across the plasma membrane rapidly, with a time constant of <0.5 ms (13,21), we were able to image action potentials. With 2 mM DPA in neurons, hVoS 2.0 gave DF/F~20% for 100 mV voltage steps. Most importantly, hVoS 2.0 gave DF/F~10% for an evoked AP, which was clearly visible in single trials.
The usefulness of hVoS probes must be weighed against concerns about the pharmacological actions of DPA. In this study, 2 mM DPA had no effect on action potentials or mEPSCs, and 4 mM DPA induced small changes. These results are virtually identical to those reported in a recent study in cultured neurons (21) . The longer decay times we observed for action potentials and mEPSPs with 4 mM DPA most likely resulted from increased membrane capacitance (Fig. 7 C) (15,29,30 ). Thus, we expect 2 mM DPA to have little if any pharmacological action. However, subtle effects remain a possibility. Even though action potentials Biophysical Journal 99 (7) 2355-2365 and mEPSPs appear unaltered by 2 mM DPA, the action potential conduction velocity decreases with increasing membrane capacitance, scaling as C m À1/2 (32) . By increasing capacitance 11%, 2 mM DPA will slow action potential conduction by 5%. With 4 mM DPA, the 32% capacitance increase will slow action potential conduction by 15%. DPA-induced changes in action potential conduction velocity could generate subtle alterations in the timing and synchrony of synaptic events, and such actions will have to be considered in studies of neural circuits. It should be noted that the theoretical analysis leading to the C m -1/2 dependence of velocity posits a linear capacitance and instantaneous charge movement. It is difficult to predict how the nonlinear and time-dependent effects of DPA will alter the relation between velocity and C m .
Our finding of very mild pharmacological actions of DPA confirms recent work by Bradley et al. (21) and fails to support the conclusions of Sjulson and Miesenböck (16) . Bradley et al. noted that this discrepancy probably arises from the sensitivity to DPA of the synaptophluorin probe used by Sjulson and Miesenböck. By quenching synaptophluorin fluorescence when it comes within range for FRET, DPA makes it difficult to use synaptophluorin as a probe to assay electrical activity. Our recordings confirm results obtained with other preparations (13, 15, 21) and indicate that 2 mM DPA induces a small capacitance increment that does not significantly dampen biological voltage changes. Thus, hVoS imaging can be performed with 2 mM DPA with few if any adverse effects on electrical activity.
The development of genetically encoded voltage sensors is expanding rapidly and attracting a great deal of attention. The results of this study clarify how hVoS depends on probe properties. We have developed a high-performance probe, hVoS 2.0, that holds promise for voltage imaging experiments. This probe provides excellent signal quality, permitting the resolution of action potentials from regions of a single cell in a single trial. It should be possible to express this probe in intact nervous systems, either by generating transgenic mice or by injecting viral vectors, or by in utero electroporation. The prospect of generating animals expressing hVOS 2.0 in different populations of neurons opens the door to imaging the electrical activity of different cell types in intact neural circuits.
APPENDIX
To evaluate the performance of the hVoS probes, we performed a theoretical analysis of how hVoS signals vary with optical and structural parameters The cumulative probability of mEPSC amplitude in 0, 2, and 4 mM DPA. Right: 4 mM DPA produced a statistically significant increase of~10%. The 10-90% rise time was not significantly changed by 2 or 4 mM DPA. The time for 37% decay increased by~15% in 4 mM DPA. For controls, 1365 mEPSCs were recorded from nine neurons; for 2 mM DPA, 948 mEPSCs were recorded from eight neurons; and for 4 mM DPA, 970 mEPSCs were recorded from eight neurons. (C) DPA increased membrane capacitance in PC12 cells. Top: Capacitive current was elicited by steps from À80 to 0 mV. Voltage steps were applied before and after 2 mM or 4 mM DPA perfusion (seven cells) for each concentration. Below: Normalized cell capacitance as a function of membrane potential before and after DPA perfusion. Different voltage steps were applied, and capacitance was calculated by dividing the integrated charge of the transient by the amplitude of the voltage step. Cell membrane capacitance was normalized to the capacitance at 0 mV in zero DPA. At 0 mV, 2 and 4 mM DPA increased the capacitance by 11% and 32%, respectively.
Biophysical Journal 99(7) 2355-2365 under experimental control. Because the DPA acceptor can be considered as confined to two parallel planes, hVoS can be treated as a two-dimensional problem, following previous theoretical studies of FRET in two dimensions (33) (34) (35) . This analysis focuses on how probe performance varies with R 0 , R d (the distance from the donor to the lipid bilayer midplane), and s (the acceptor membrane density).
In hVoS, FRET occurs between the XFP donor, labeled F, and the DPA acceptor, labeled A in the sketch in the upper-left corner of Fig. 4 . The measured fluorescence signal, F, is the product of the fluorescence in the absence of DPA, F 0 , times the probability of no quenching by FRET. Taking Q as the probability of FRET between a particular donor and any acceptor, we have
Define P(r) as the probability that no FRET will occur to an acceptor located inside a circle of radius r centered at the location of the donor projected on a plane in the membrane. Then for a circle with a slightly larger radius rþdr, Pðr þ drÞ ¼ PðrÞð1 À qðrÞdrÞ (A2)
where q(r) is the probability that FRET will occur with an acceptor at distance r. Because of the inverse 6th power dependence of FRET, we have
where the donor-acceptor distance was taken as ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi R 2 a þ r 2 p , R a equals either R 1 or R 2 (Fig. 4) , and s is the density of acceptor molecules with units of number/area. The numerator of Eq. A3 is the number of molecules in an infinitesimally thin ring with radius r. Equations A2 and A3 lead to the differential equation
which can be solved to give
where the substitution u ¼ (R a 2 þ r 2 )/R 0 2 was made. The probability of no quenching is simply this function evaluated at r ¼ N:
Taking Q ¼ 1 À P N allows us to compute the fluorescence signal in Eq. A1. At an extreme negative voltage, we assume that all of the DPA is on the outer surface, in the plane at R 1 (Fig. 4, sketch) . P N is then computed from Eq. A6 using R 1 as R a in the lower limit of the integral, whereas for positive voltages we use R 2 . The maximal fluorescence change is then DF max ¼ F 0 ðP N ðR 1 Þ À P N ðR 2 ÞÞ (A7)
For DF/F we have
To evaluate the S/N ratio for shot noise, we note that the noise increases with the square root of the light intensity (31):
S=N a ðP N ðR 1 Þ À P N ðR 2 ÞÞ=ðP N ðR 2 ÞÞ
1=2 (A9)
where s was estimated from the increment in capacitance. Here, 4 mM DPA increased the membrane capacitance by 32% (Fig. 7 C) . With a specific membrane capacitance of 0.9 mF/cm 2 (36) and an effective charge movement of 0.6 per molecule (29,30), we obtained s ¼ 10 À4 DPA molecules/Å 2 . The acyl chain carbonyls of dioleoylphosphatidylcholine are separated by 29 Å (37), so we can take the distance between the two planes populated by DPA as~25 Å . Now we can express everything in terms of R d by taking R 1 ¼ R d þ 12.5 Å and R 2 ¼ R d À 12.5 Å . This defines P N in Eq. A6 and allows us to use Eqs. A7-A9 to calculate indices of performance for changes between the extremes of positive and negative voltages. These equations were evaluated with MATHCAD 14, which performs numerical integration. MATHCAD was also used to maximize these quantities as functions of R 0 and R d . Biophysical Journal 99(7) 2355-2365
